Table 3 Age-adjusted incidence rates per 100,000 person-years.
From: Racial Differences in Four Leukemia Subtypes: Comprehensive Descriptive Epidemiology
Age ≤ 14 | Age > 14 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
HW | NHW | BL | API | HW | NHW | BL | API | ||
ALL | |||||||||
Total | 5.3(5,5.5) | 3.9(3.8,4.1) | 1.9(1.7,4.1) | 3.3(3.1,3.6) | Total | 1.6(1.5,1.7) | 0.8(0.8,0.9) | 0.6(0.6,0.9) | 0.8(0.7,0.8) |
Male | 5.8(5.4,6.1) | 4.2(4,4.4) | 2.2(1.9,4.4) | 3.7(3.3,4.1) | Male | 1.8(1.6,1.9) | 1(1,1.1) | 0.7(0.6,1.1) | 0.9(0.8,1) |
Female | 4.7(4.5,5) | 3.6(3.4,3.8) | 1.6(1.4,3.8) | 2.9(2.6,3.3) | Female | 1.4(1.3,1.5) | 0.7(0.6,0.7) | 0.6(0.5,0.7) | 0.6(0.6,0.7) |
≤4 | 8(7.5,8.4) | 6.8(6.5,7.1) | 2.6(2.3,7.1) | 5.8(5.2,6.4) | 15–34 | 1.7(1.6,1.8) | 0.8(0.8,0.9) | 0.5(0.4,0.9) | 0.7(0.6,0.8) |
5–9 | 4.6(4.3,5) | 3.3(3.1,3.5) | 1.7(1.5,3.5) | 3(2.5,3.4) | 35–54 | 1.1(1,1.3) | 0.6(0.5,0.6) | 0.5(0.4,0.6) | 0.5(0.5,0.6) |
10–14 | 3.3(3,3.6) | 1.9(1.7,2.1) | 1.3(1.1,2.1) | 1.4(1.1,1.7) | 55+ | 2.1(1.8,2.3) | 1.2(1.2,1.3) | 0.9(0.8,1.3) | 1.1(1,1.3) |
CLL * | |||||||||
Total | — | — | — | — | Total | 2.9(2.7,3) | 6.9(6.8,7) | 4.4(4.2,7) | 1.4(1.3,1.4) |
Male | — | — | — | — | Male | 3.9(3.6,4.2) | 9.6(9.4,9.7) | 6.3(5.9,9.7) | 1.9(1.8,2.1) |
Female | — | — | — | — | Female | 2.1(2,2.3) | 4.9(4.8,5) | 3.2(3,5) | 0.9(0.8,1) |
≤4 | — | — | — | — | 15–34 | — | — | — | — |
5–9 | — | — | — | — | 35–54 | 0.6(0.6,0.7) | 2(2,2.1) | 1.3(1.2,2.1) | 0.4(0.4,0.5) |
10–14 | — | — | — | — | 55+ | 9.6(9,10.1) | 22.5(22.2,22.8) | 14.4(13.7,22.8) | 4.3(4,4.7) |
AML | |||||||||
Total | 0.8(0.7,0.8) | 0.6(0.6,0.7) | 0.7(0.6,0.7) | 0.7(0.6,0.9) | Total | 3.9(3.8,4.1) | 4.7(4.6,4.8) | 3.9(3.7,4.8) | 4(3.8,4.1) |
Male | 0.8(0.7,1) | 0.6(0.6,0.7) | 0.7(0.5,0.7) | 0.8(0.6,1) | Male | 4.8(4.5,5.1) | 5.9(5.8,6) | 4.7(4.4,6) | 4.7(4.5,5) |
Female | 0.7(0.6,0.8) | 0.6(0.5,0.7) | 0.7(0.5,0.7) | 0.7(0.5,0.9) | Female | 3.4(3.2,3.6) | 3.9(3.8,3.9) | 3.4(3.2,3.9) | 3.4(3.2,3.6) |
≤4 | 1(0.8,1.2) | 0.9(0.8,1) | 1(0.8,1) | 1.1(0.8,1.4) | 15–34 | 1.2(1.1,1.3) | 1(0.9,1) | 0.8(0.7,1) | 1.1(1,1.2) |
5–9 | 0.5(0.4,0.6) | 0.4(0.3,0.5) | 0.4(0.3,0.5) | 0.4(0.3,0.6) | 35–54 | 2.1(2,2.3) | 2.1(2,2.2) | 2(1.9,2.2) | 2.2(2,2.4) |
10–14 | 0.8(0.6,1) | 0.6(0.5,0.7) | 0.6(0.4,0.7) | 0.7(0.5,0.9) | 55+ | 10(9.5,10.6) | 13.1(12.9,13.3) | 10.5(9.9,13.3) | 10.2(9.7,10.7) |
CML | |||||||||
Total | 0.1(0.1,0.1) | 0.1(0.1,0.1) | — | — | Total | 1.8(1.7,2) | 2.2(2.2,2.3) | 2(1.9,2.3) | 1.5(1.4,1.6) |
Male | 0.1(0.1,0.2) | 0.1(0.1,0.2) | — | — | Male | 2.4(2.2,2.6) | 3(2.9,3) | 2.7(2.5,3) | 2.1(1.9,2.3) |
Female | — | 0.1(0,0.1) | — | — | Female | 1.4(1.3,1.6) | 1.7(1.6,1.8) | 1.5(1.4,1.8) | 1.1(1,1.2) |
≤4 | — | — | — | — | 15–34 | 0.5(0.5,0.6) | 0.4(0.4,0.5) | 0.5(0.4,0.5) | 0.5(0.4,0.6) |
5–9 | — | — | — | — | 35–54 | 1.3(1.2,1.4) | 1.3(1.2,1.3) | 1.4(1.3,1.3) | 1.1(0.9,1.2) |
10–14 | — | — | — | — | 55+ | 4.3(4,4.7) | 6(5.8,6.1) | 4.9(4.5,6.1) | 3.5(3.2,3.8) |
